Rosai-dorfman Disease
What's New
Last Posted: Oct 16, 2023
- Impact of BRAF mutation on aggressiveness and outcomes in adult clonal histiocytosis.
Jerome Razanamahery, et al. Frontiers in immunology 2023 0 1260193 - Molecular and clinicopathologic characterization of pediatric histiocytoses.
Zofia Hélias-Rodzewicz, et al. American journal of hematology 2023 0 - Rosai-Dorfman Disease with Activating KRAS Mutation - Response to Cobimetinib.
Jacobsen Eric, et al. The New England journal of medicine 2017 0 (24) 2398-2399 - [Rosai-Dorfman disease: a clinicopathologic analysis and whole exome sequencing in 23 cases].
Fu W J, et al. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2019 0 (8) 656-661 - Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis.
Janku Filip, et al. Molecular cancer therapeutics 2019 0 (6) 1149-1157 - Rosai-Dorfman Disease Displays a Unique Monocyte-Macrophage Phenotype Characterized by Expression of OCT2.
Ravindran Aishwarya, et al. The American journal of surgical pathology 2020 0 (1) 35-44 - Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G?>?A mutation in the SLC29A3 gene.
Chouk Hamza, et al. Human genomics 2021 0 (1) 63 - Clinicopathological and Gene Mutation Analysis of 27 Cases with Extranodal Rosai-Dorfman Disease.
Tang Ming, et al. Journal of inflammation research 2022 0 2775-2787 - Cyclin D1 Expression and Molecular Genetic Findings in Periocular Histiocytoses and Neoplasms of Macrophage-Dendritic Cell Lineage.
Milman Tatyana, et al. American journal of ophthalmology 2022 0 36-51 - Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
Garces Sofia, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 6
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 01, 2024
- Content source: